The interaction between platelets and factor VII/VIIa.
Blood coagulation normally occurs when factor VII interacts with its specific cellular receptor, tissue factor, which is exposed when a blood vessel is severed. The factor VII/tissue factor complex then initiates a cascade of proteolytic reactions involving factors IX, X, prothrombin and fibrinogen, culminating in the formation of a fibrin clot. The role of platelets in the initiation phase of blood coagulation is still unclear. It has been postulated that platelets bind activated factor VIIa independently of tissue factor, and that this interaction forms the basis of the usefulness of high-dose recombinant factor VIIa in treating hemophiliacs with inhibitory antibodies, and other thrombocytopenia-like syndromes. In this review, we will examine the evidence for and against such an hypothesis, as well as discuss an alternative mechanism for the efficacy of high-dose factor VIIa in treating hemophilic patients with inhibitors.
Department of Laboratory Medicine and Pathobiology, Room 2-015, St. Michael's Hospital, University of Toronto, 30 Bond Street, Toronto, Ont., Canada M5B 1W8. lauh@smh.toronto.on.ca
Herbert K F
HK
Lau
D001777:Blood Coagulation; D001792:Blood Platelets / Q000502:physiology*; D005167:Factor VII / Q000502:physiology; D015942:Factor VIIa / Q000378:metabolism / Q000502:physiology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy; D006801:Humans; D013921:Thrombocytopenia / Q000188:drug therapy
D005167:Factor VII; D015942:Factor VIIa